“…a revolution in the approach of endometrial cancer.”

The molecular diagnostic test GynEC®-DX, developed by Reig Jofre, has meant “a revolution in the approach of endometrial cancer”, points out to ConSalud.es, Jordi Ponce, Head of the Service of the University Hospital of Bellvitge and Vice-President of Oncology Section of SEGO .

See interview